Efficacy of Multidimensional Management of Mild Traumatic Brain Injury
1 other identifier
interventional
221
1 country
6
Brief Summary
Unfavorable outcomes (UO) are seen in 15 to 20% of patients with mild traumatic brain injury (mTBI). Early identification of patients at risk for UO is crucial for suitable management to be initiated, increasing their chances for a return to a normal life. The investigators previously developed a diagnostic tool enabling early identification (8 to 21 days after the injury) of patients likely to develop UO. In the present study, the investigators examined the value and beneficial effects of early multidimensional management (MM) on prognosis. The investigators used a diagnostic tool to classify 221 mTBI patients as UO (97) or FO (favorable outcome) (124). Patients whose initial risk factors point to UO are at risk of developing post-concussion syndrome (PCS). UO patients were randomized into 2 groups: a group that underwent MM (cognitive-behavioral rehabilitation) (34) and a group with no specific management (46). At 6 months, these 2 groups were compared and the impact of MM on outcome was assessed. Among patients initially classified as FO (101), 95% had FO at 6 months and only 5 had PCS as defined by DSM-IV classification. Of the UO patients who received MM, 94% had no PCS 6 months after injury, whereas 52% of the UO patients who did not receive MM had persistent PCS. The effect of MM on the recovery of patients at 6 months, once adjusted for the main confounding factors, was statistically significant (p\<0.001). These results show that the initiation of MM after early identification of at-risk mTBI patients can considerably improves their prognosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2012
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2013
CompletedFirst Submitted
Initial submission to the registry
January 18, 2019
CompletedFirst Posted
Study publicly available on registry
January 22, 2019
CompletedJanuary 24, 2019
January 1, 2019
1.2 years
January 18, 2019
January 23, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in quality of life
Change in quality of life assessed by QOLIBRI (Quality of Life after Brain Injury) Scale - QOLIBRI scale assess health-related quality of life (HRQoL) of individuals after traumatic brain injury. QOLIBRI is a comprehensive questionnaire with 37 items covering six dimensions of HRQoL after TBI. The QOLIBRI scores are reported on a 0-100 scale , where 0=worst possible quality of life and 100=best possible quality of life.
Baseline, 6 months -
Study Arms (2)
Intervention
EXPERIMENTALPatient who underwent cognitive-behavioral rehabilitation
Comparator
NO INTERVENTIONPatient with no specific management
Interventions
Combination of clinical examination and neuropsychological and psychological tests
Eligibility Criteria
You may qualify if:
- \- Patients aged 18 to 65 who have suffered mTBI, have health care coverage, who understand French, who can be followed for 6 months, and who are able to understand, reply, and cooperate.
You may not qualify if:
- Patient intubated and/or ventilated and/or sedated upon arrival at hospital
- Patient with injury to the medulla and with neurological signs or multiple injuries (at least 1 of which is life-threatening)
- Brain injury incurred during a suicide attempt
- Patient presenting psychiatric or psychological disorders that are debilitating and/or interfere with follow-up and/or evaluation
- Psychoactive treatment ongoing at the time of injury
- History of hospitalization in specialized a psychiatric setting and/or sick leave for psychological reasons
- Patient with a neurological disorder
- Patient with substance dependence
- Subject under guardianship or wardship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Chu Bicetre
Le Kremlin-Bicêtre, France
Chu Montpellier
Montpellier, France
Chu Bichat/Beaujon
Paris, France
CHU St ANTOINE
Paris, France
Chu Tenon
Paris, France
Chu Rouen
Rouen, France
Related Publications (1)
Caplain S, Chenuc G, Blancho S, Marque S, Aghakhani N. Efficacy of Psychoeducation and Cognitive Rehabilitation After Mild Traumatic Brain Injury for Preventing Post-concussional Syndrome in Individuals With High Risk of Poor Prognosis: A Randomized Clinical Trial. Front Neurol. 2019 Sep 4;10:929. doi: 10.3389/fneur.2019.00929. eCollection 2019.
PMID: 31551902DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 18, 2019
First Posted
January 22, 2019
Study Start
April 1, 2012
Primary Completion
June 30, 2013
Study Completion
June 30, 2013
Last Updated
January 24, 2019
Record last verified: 2019-01